SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA -- Ignore unavailable to you. Want to Upgrade?


To: Joe who wrote (91)5/12/1999 9:09:00 AM
From: Alan A. Hicks  Respond to of 253
 
STAAR broke out of a 10 1/2 month downtrend yesterday on 4.5 times average daily volume. STAAR also broke above its 200-day moving average which should now begin to move sideways. The 200-day moving average is an important long-term trend indicator by chartists.

By classical chart analysis STAA has broken its long-term down trend and is building a base between $7 1/4 and $11. A break above $11 and the 200-day moving average turning up would confirm a new long-term uptrend has begun for STAAR.

Given that STAAR will finish clinical trials on the glaucoma wick and ICL over the next few months and with the new Toric IOL now ramping up and the new collamer material for IOLS, chances look good for STAAR to break above the $11 level and trend up towards its highs of $18 - $19.



To: Joe who wrote (91)5/13/1999 2:33:00 PM
From: HerbVic  Read Replies (1) | Respond to of 253
 
Does anyone have an expectation of where to expect resistance on BEAM's climb? It bumped off of 19 on May 3. Will it do so again, or will it plod on upwards?

Also, shouldn't there be some news soon to the effect of reinforcing the Management's position vis-à-vis the recent merger? I would think that the synergies between the two companies have yet to be expressed fully.

HerbVic